Human KDR / VEGFR2 Antibody (Ramucirumab, Research Use)

产品名称	Human KDR / VEGFR2 Antibody (Ramucirumab, Research Use)
目录号	NBR-0089
别名	VEGFR2; FLK1; Vascular Endothelial Growth Factor Receptor 2; VEGFR; CD309
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0089-100UG	100ug	￥550	请咨询
NBR-0089-1MG	1mg	￥3500	请咨询
NBR-0089-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human KDR / VEGFR2 Antibody (Ramucirumab, Research Use)
产品编号：NBR-0089
针对靶点：KDR / VEGFR2
抗体药商品名：Ramucirumab
抗体药描述：Ramucirumab (Cyramza) is the first FDA-approved agent to reduce tumor angiogenesis by targeting the extracellular domain of the VEGFR.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: KDR / VEGFR2
Synonyms: VEGFR2; FLK1; Vascular Endothelial Growth Factor Receptor 2; VEGFR; CD309
Target Description: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis.
Ensembl: ENSG00000128052
Uniprot: P35968